Home › Chemotherapy › Which Chemotherapy Drugs — Cause Hair Loss?

Side effects of chemotherapy

Which Chemotherapy Drugs Cause Hair Loss?

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

Hair loss is one of the most feared side effects of chemotherapy — but it depends entirely on which drugs you are receiving. Some cause near-certain complete loss. Others cause only thinning. And some rarely affect hair at all.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

Prescription-only medicine.

Chemotherapy is a prescription-only treatment administered under the direct supervision of a qualified oncologist in a hospital or specialist cancer centre. Nothing on this page should be used to start, stop, or modify any chemotherapy treatment — that decision belongs entirely to your treating team. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Hair loss depends on which chemotherapy drug you are receiving. Anthracyclines such as doxorubicin and taxanes such as docetaxel cause near-certain complete hair loss. Platinum agents such as carboplatin usually cause thinning only. Oxaliplatin and gemcitabine are associated with very low rates of hair loss. Your oncologist can tell you what to expect from your specific regimen.

In detail

Which chemotherapy drugs cause near-certain hair loss?

Anthracyclines and taxanes are the two drug groups most reliably associated with complete scalp hair loss. Doxorubicin (brand name Adriamycin; Indian brands include Doxocin) and epirubicin (Farmorubicin) are anthracyclines used widely in breast, stomach, and lymphoma treatment. Docetaxel (Taxotere; Indian brands include Docel and Docetaz) and paclitaxel (Taxol; Indian brands include Intaxel and Paclibet) are taxanes given in breast, lung, and ovarian cancer treatment.

Cyclophosphamide (Endoxan), at the doses used in most solid-tumour regimens, causes substantial hair loss — particularly when combined with an anthracycline. Ifosfamide (Holoxan) and etoposide (Vepesid) cause significant hair loss in the regimens where they appear.

On these drugs, complete scalp hair loss is the expected outcome for most people — not an unusual side effect.

Checklist

What should you arrange before your first cycle if significant hair loss is expected?

Ask your oncologist whether scalp cooling is suitable for your drug — it is not appropriate for all regimens.
Cut your hair shorter before loss begins. Many people find a gradual change easier than sudden loss.
Source a wig, scarf, or head covering before treatment starts, not after hair begins to fall.
Ask your treatment centre whether they have a wig bank or can refer you to a subsidised service.
Prepare close family for what to expect so they are not alarmed when it happens.

Step by step

What happens to hair during and after chemotherapy?

First few weeks

The scalp may feel tender or sensitive before visible loss begins. This is the follicle responding to the drug.

Hair begins to shed

On high-risk drugs such as anthracyclines and taxanes, visible shedding typically begins within the first few weeks. Many people choose to shave the scalp at this point rather than wait.

Maximum loss

Most scalp hair is usually lost within the first two cycles on high-risk drugs. Eyelashes, eyebrows, and body hair may thin or fall as well, though this varies between people.

During the rest of treatment

Hair stays absent or very sparse while the drug continues. This is expected and does not indicate anything about how the treatment is working.

Regrowth begins

For most people, regrowth starts within weeks of completing treatment. Initial growth is often soft and fine, and may be a slightly different texture or shade at first.

Eligibility

Who is chemotherapy not suitable for?

Chemotherapy is not suitable for everyone. Eligibility depends on the specific drug, the cancer type and stage, and the individual's overall health. The groups below are frequently not candidates, or require significant modification before treatment can proceed:

People with severely reduced bone marrow function who cannot safely tolerate further suppression
People with severe kidney or liver impairmentMost chemotherapy drugs are processed through one or both of these organs
People who are pregnant, particularly in the first trimesterThe risk to the developing fetus is significant with most agents
People with active, uncontrolled serious infections
People whose general health and performance status are too poor to tolerate treatment safely
People with significant pre-existing heart disease when anthracyclines such as doxorubicin are being considered

Eligibility in each case is decided by a qualified oncologist based on the individual's complete clinical picture. This list is not a self-assessment tool.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

In detail

Which chemotherapy drugs are unlikely to cause complete hair loss?

Platinum agents cause thinning in a proportion of patients but rarely complete scalp hair loss. Carboplatin (Kemocarb, Carbotax) and cisplatin (Cisteen, Platinol) are the platinum drugs most commonly used in India. Oxaliplatin (Eloxatin, Oxalip) is associated with very low rates of hair loss.

Gemcitabine (Gemita, Gemzar) causes mild to moderate thinning in some patients. 5-Fluorouracil (Fluracil) and its oral form capecitabine (Xeloda, Capejoy) cause thinning in a proportion of patients but complete loss is uncommon. Methotrexate causes thinning at the doses used in most cancer regimens.

When any of these drugs is combined with a high-risk drug such as a taxane or anthracycline, the combination — not the individual drug — determines the hair effect. Ask your team about your full regimen.

Question by question

Why do some chemotherapy drugs cause complete hair loss and others barely affect hair?

The biology: why certain drugs hit hair follicles harder

Hair follicles divide rapidly, which makes them sensitive to the same mechanism that makes fast-dividing cancer cells sensitive to chemotherapy. Drugs that most aggressively interrupt rapid cell division — particularly anthracyclines and taxanes — affect follicles most severely. Drugs that work through different mechanisms, or that reach follicle tissue at lower concentrations, cause less hair effect. This is why the hair outcome differs so much between drug classes rather than being a uniform side effect of all chemotherapy.

Does scalp cooling actually work?

Scalp cooling reduces blood flow to the scalp during the infusion, limiting how much drug reaches the hair follicles. It can reduce — though not always prevent — hair loss in a proportion of patients on taxane-based regimens. It is not suitable for all drug types and must be arranged before treatment starts. Your oncologist will tell you whether it is appropriate for your specific regimen, and what degree of protection is realistic to expect.

Will I also lose my eyebrows and eyelashes?

On anthracyclines and taxanes, eyelashes, eyebrows, and body hair frequently thin or fall alongside scalp hair, though the degree varies between people. The timing is often slightly later than scalp hair loss. On drugs with a lower hair-loss profile — carboplatin, gemcitabine, 5-FU — noticeable loss of eyebrows or eyelashes is less common. Your oncology team can tell you what to expect from your specific drug combination.

Are there oils or traditional treatments that prevent chemotherapy hair loss?

No oil, herb, supplement, or traditional preparation has been shown in clinical evidence to prevent chemotherapy-associated hair loss. Scalp cooling is the only intervention with meaningful clinical evidence, and even that is drug-specific. If you are applying anything to your scalp or taking any preparation during treatment, tell your oncology team — some products irritate a chemotherapy-sensitised scalp, and some may interact with treatment. Your team needs to know and will not judge you for asking.

I am on two drugs. How do I know which one is causing the hair loss?

In a combination regimen it is usually not possible to isolate which drug is responsible — both may be contributing. Ask your oncologist what hair loss is typical for the specific combination you are receiving, using the regimen name. That gives you a more reliable answer than adding the expected effects of each drug separately, since combinations can behave differently from either drug given alone.

Worth knowing

Did you know?

For most people on anthracyclines or taxanes, scalp hair begins to regrow within weeks of completing treatment.

Chemotherapy-induced hair loss is one of the most reliably reversible side effects of cancer treatment.

Source: ESMO Clinical Practice Guidelines, Supportive and Palliative Care

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Will my hair definitely grow back after chemotherapy?

For the vast majority of people, yes. Hair loss from anthracyclines and taxanes is almost always temporary. Regrowth begins for most people within weeks of completing treatment. Permanent significant hair loss from chemotherapy is uncommon and is not the expected outcome — it is something your oncologist would raise with you directly if it were a concern for your specific situation, not something you should discover by searching.

How long does it take for hair to grow back after chemotherapy?

Regrowth typically begins within a few weeks of completing treatment, with visible growth usually noticeable within the first couple of months. How long it takes to return to your previous length depends on your hair before treatment and your natural rate of growth. Texture and colour may be slightly different in the early months of regrowth, but this usually settles as the hair grows out.

Does losing hair mean the chemotherapy is working?

No. Hair loss happens because chemotherapy affects all rapidly dividing cells — including hair follicles — not because it is specifically targeting the cancer. Two people on the same drug can have very different amounts of hair loss and similar responses to treatment. Hair loss tells you something about how the drug works in the body. It tells you nothing about whether the cancer is responding.

Can I colour or treat my hair during chemotherapy?

Most oncology teams advise against chemical treatments — colour, perms, relaxers — during chemotherapy. The scalp is more sensitive during treatment, and chemicals that would normally be tolerated may cause irritation or damage. Gentle washing and avoiding heat are the usual guidance. Ask your own team what they recommend, because the advice may vary depending on your drug and how your scalp is responding.

What does scalp cooling feel like, and does it work for my drug?

Scalp cooling involves wearing a cold cap or hood throughout the infusion. It feels uncomfortably cold — some people tolerate it well and others do not. Whether it is appropriate depends on your specific drug: it has the most evidence for taxane-based regimens and less for anthracyclines. It is not suitable for some haematological cancers. If you are interested, ask before your first cycle — it must be arranged in advance and cannot be started partway through treatment.

My drug is not on the high-risk list. Does that mean I will not lose hair?

Not necessarily — your risk is lower, but even drugs with a lower profile cause thinning in some people. Individual response varies with the dose, the combination, and how your body processes the drug. Your oncologist's estimate for your full regimen is more useful than a general comparison, because it accounts for the specific combination and doses you are receiving. Report any change that concerns you rather than comparing yourself to a list.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index